Key Metrics
5.6
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.005 - 0.01
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.8
5-Year SI
5-year SI
- 0.78 2-year SI
- 0.79 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Pharmacology
SJR
- Q2 Pharmacology
- Q2 Infectious Diseases
- Q2 Pharmacology (medical)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.37
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Staphylococcus aureus
- Pneumonia
- Bacteremia
- Escherichia coli
- Tuberculosis
- Virus
- Klebsiella pneumoniae
- Meningitis
- Staphylococcus
- Antibiotic resistance
- Genotype
- Antimicrobial
- Fluconazole
- Intensive care
- Pseudomonas aeruginosa
- Intensive care unit
- Enterobacteriaceae
- Plasmid
- Cross-sectional study
- Serotype
Journal Specifications
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2836 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2008 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 16 |
| Article Processing Charges | USD 2836 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in Infection and Drug Resistance ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Clinical Manifestation, mNGS Based Diagnosis and Treatment of Pulmonary Mucormycosis with Rhizopus delemar in a Diabetic Patient.
- 1 Apr 24
- Infection and drug resistance
-
Full paper
The Emergence of Candida auris is Not Associated with Changes in Antifungal Prescription at Hospitals.
- 1 Apr 24
- Infection and drug resistance
-
Full paper
Nirmatrelvir-Ritonavir Reduced Mortality in Hospitalized Patients with COVID-19 During the Omicron Outbreak: Real-World Evidence from Beijing.
- 1 Apr 24
- Infection and drug resistance
-
Full paper
Successful Treatment of an AML Patient Infected with Hypervirulent ST463 Pseudomonas Aeruginosa Harboring Rare Carbapenem-Resistant Genes blaAFM-1 and blaKPC-2 Following Allogeneic Hematopoietic Stem Cell Transplantation.
- 1 Apr 24
- Infection and drug resistance
-
Full paper
EMR Combined with CRB-65 Superior to CURB-65 in Predicting Mortality in Patients with Community-Acquired Pneumonia [Response to Letter].
- 1 Apr 24
- Infection and drug resistance
-
Full paper
Survival Rate and Predictors of Mortality Among TB-HIV Co-Infected Patients During Tuberculosis Treatment at Public Health Facilities in Bahir Dar City, Northwest Ethiopia.
- 1 Apr 24
- Infection and drug resistance
Scite analysis
Powered by scite_
3.5k articles received 33.9k citations see all
- 2,506 Supporting
- 29,936 Mentioning
- 645 Contrasting
Editorial notices
- 5 Retractions
- 0 Withdrawals
- 0 Corrections
- 37 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
50%
4 to 6 months
47%
7 to 9 months
3%
Above 9 months
0%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Infection and Drug Resistance been actively publishing?
Infection and Drug Resistance has been in operation since 2008 till date.
What is the publishing frequency of Infection and Drug Resistance ?
Infection and Drug Resistance published with a Continuous publication frequency.
How many articles did Infection and Drug Resistance publish last years ?
In 2023, Infection and Drug Resistance published 661 articles.
What is the eISSN & pISSN for Infection and Drug Resistance ?
For Infection and Drug Resistance,eISSN is 1178-6973 and pISSN is1178-6973.
What is Citescore for Infection and Drug Resistance ?
Citescore for Infection and Drug Resistance is 5.6.
What is SNIP score for Infection and Drug Resistance ?
SNIP score for Infection and Drug Resistance is 1.37.
What is the SJR for Infection and Drug Resistance ?
SJR for Infection and Drug Resistance is Q2.
Who is the publisher of Infection and Drug Resistance ?
DOVE MEDICAL PRESS LTD is the publisher of Infection and Drug Resistance.